Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-113919

Lineage Cell Therapeutics, Inc. · LCTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Aditya P. Mohanty
Officer — Co-Chief Executive Officer · Director
Period of report
Apr 7, 2016
Accepted (ET)
Apr 11, 2016 · 9:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Shares, no par valueF1Apr 11, 2016A67,567$2.96A67,567D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Option to Purchase Common SharesF2$3.16Apr 7, 2016A375,000A—Apr 6, 2026Common Shares375,000375,000D
Restricted Stock UnitsF3,F4—Apr 11, 2016A75,000A——Common Shares75,00075,000D
Option to Purchase Common SharesF5$3.78holding————Dec 28, 2024Common Shares675,000675,000D

Explanation of responses